Evidence map›Paper›PMID 31327509›Full record

ArticleAmerican journal of human genetics2019

Family Clustering of Autoimmune Vitiligo Results Principally from Polygenic Inheritance of Common Risk Alleles.

Genevieve H L Roberts, Subrata Paul, Daniel Yorgov, Stephanie A Santorico, Richard A Spritz

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Treatment Advances in Vitiligo: An Updated Review.Dermatology practical & conceptual · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The genetic architecture of vitiligo.Pigment cell & melanoma research · 2020
    Review
  14. Update on the pathogenesis of vitiligo.Anais brasileiros de dermatologia
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Genevieve H L RobertsHuman Medical Genetics and Genomics Program, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA.
Subrata PaulDepartment of Mathematical and Statistical Sciences, University of Colorado Denver, Denver, CO 80217, USA.
Daniel YorgovDepartment of Mathematical Sciences, Purdue University Fort Wayne, Fort Wayne, IN 46805, USA.
Stephanie A SantoricoHuman Medical Genetics and Genomics Program, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Mathematical and Statistical Sciences, University of Colorado Denver, Denver, CO 80217, USA; Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Aurora, CO 80045, USA; Division of Biomedical Informatics and Personalized Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Richard A SpritzHuman Medical Genetics and Genomics Program, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: Richard.Spritz@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USColorado School of Public Health · USIndiana University – Purdue University Fort Wayne · USUniversity of Colorado Denver · US

Funding

VitGene International Consortium to Identify Susceptibility Genes for GeneralizedR01AR056292 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SPRITZ, RICHARD ANDREW · 2008 to 2016
$6.9M
Transgenic and Gene Targeting CoreP30AR057212 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI NORRIS, DAVID A. · 2009 to 2018
$6.2M
Training in Translational Research of Skin DiseasesT32AR007411 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI ASGARI, MARYAM MANDANA, ROOP, DENNIS · 1986 to 2025
$4.8M
Identification and Functional Analyses of Common and Rare Causal Variants in SLAR01AR065951 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SPRITZ, RICHARD ANDREW · 2014 to 2016
$1.2M
PHOSPHOLIPASE D AND KERATINOCYTE DIFFERENTIATIONR01AR045212 · NIAMS · MEDICAL COLLEGE OF GEORGIA (MCG) · PI BOLLAG, WENDY B · 1999 to 2007
$1.1M
NIAMS NIH HHS P30 AR057212NIAMS NIH HHS R01 AR045212NIAMS NIH HHS R01 AR056292NIAMS NIH HHS R01 AR065951NIAMS NIH HHS T32 AR007411
6 · The paper itself

Abstract

Vitiligo is an autoimmune disease that results in patches of depigmented skin and hair. Previous genome-wide association studies (GWASs) of vitiligo have identified 50 susceptibility loci. Variants at the associated loci are generally common and have individually small effects on risk. Most vitiligo cases are "simplex," where there is no family history of vitiligo, though occasional family clustering of vitiligo occurs, and some "multiplex" families report numerous close affected relatives. Here, we investigate whether simplex and multiplex vitiligo comprise different disease subtypes with different underlying genetic etiologies. We developed and compared the performance of several different vitiligo polygenic risk scores derived from GWAS data. By using the best-performing risk score, we find increased polygenic burden of risk alleles identified by GWAS in multiplex vitiligo cases relative to simplex cases. We additionally find evidence of polygenic transmission of common, low-effect-size risk alleles within multiplex-vitiligo-affected families. Our findings strongly suggest that family clustering of vitiligo involves a high burden of the same common, low-effect-size variants that are relevant in simplex cases. We furthermore find that a variant within the major histocompatibility complex (MHC) class II region contributes disproportionately more to risk in multiplex vitiligo cases than in simplex cases, supporting a special role for adaptive immune triggering in the etiology of multiplex cases. We suggest that genetic risk scores can be a useful tool in analyzing the genetic architecture of clinical disease subtypes and identifying subjects with unusual etiologies for further investigation.

Indexed as

Genetic Predisposition to DiseaseMultifactorial InheritancePolymorphism, Single NucleotideAllelesAutoimmune DiseasesCase-Control StudiesFamilyFemaleGenesGenome-Wide Association StudyGenotypeHumansMaleRisk FactorsVitiligoautoimmunityfamily clusteringgenetic architecturegenetic risk scorepolygenic inheritancevitiligo

Identifiers

PMID31327509
PMCPMC6698884
OpenAlexW2960169260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.